Industry players revealed a focus on reducing operational costs and improving safety with new vocational vehicles, alongside the use of smarter telematics solutions designed ...

The CDSCO said advertisements — including surrogate promotions — across print, electronic, digital or social media platforms ...

CDSCO warned that any form of advertisement -- direct or indirect -- promoting such medicines to the general public could ...

As pharmaceutical companies intensify competition to capture a share of the fast-growing anti-obesity drug market, India’s drug regulator has cautioned firms against engaging in direct or indirect ...

State mandates, federal proposals, and ongoing legal battles are reshaping how collision repair shops access vehicle data, diagnostics, and repair procedures.

India’s Central Drugs Standard Control Organization warns pharma companies against promoting GLP-1 receptor agonists directly to consumers.

An urgent recall notice has been issued for a boiler model over fears it could leak carbon monoxide and expose people to ...

Any advertisement, direct or indirect, that promotes prescription medicines to the general public, inflates efficacy claims or implies guaranteed weight loss outcomes will be deemed misleading and can ...

Exterior cladding functions as the first layer of defense between a structure and environmental exposure”— Elwin ...

India’s CDSCO warns pharma companies against promoting prescription weight-loss drugs like Semaglutide and Liraglutide to the public, urging ethical marketing and holistic obesity care.